Evidence map›Paper›PMID 34326347›Full record

ArticleNature communications2021

Nuclear condensates of p300 formed though the structured catalytic core can act as a storage pool of p300 with reduced HAT activity.

Yi Zhang, Kyle Brown, Yucong Yu, Ziad Ibrahim, Mohamad Zandian, Hongwen Xuan, Steven Ingersoll, Thomas Lee, Christopher C Ebmeier, Jiuyang Liu and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Targeting lysine acetylation readers and writers.Nature reviews. Drug discovery · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Yi ZhangDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA.ORCID 0000-0001-8170-9983
Kyle BrownDepartment of Chemistry, University of Colorado, Denver, CO, USA.
Yucong YuCenter for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA.
Ziad IbrahimDepartment of Molecular and Cell Biology, Leicester Institute of Structural and Chemical Biology, University of Leicester, Leicester, UK.
Mohamad ZandianDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA.ORCID 0000-0002-4967-6867
Hongwen XuanCenter for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA.
Steven IngersollDepartment of Chemistry, University of Colorado, Denver, CO, USA.
Thomas LeeDepartment of Biochemistry, University of Colorado, Boulder, CO, USA.
Christopher C EbmeierDepartment of Biochemistry, University of Colorado, Boulder, CO, USA.ORCID 0000-0001-7940-6190
Jiuyang LiuDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA.
Daniel PanneDepartment of Molecular and Cell Biology, Leicester Institute of Structural and Chemical Biology, University of Leicester, Leicester, UK.
Xiaobing ShiCenter for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA.ORCID 0000-0001-5242-8189
Xiaojun RenDepartment of Chemistry, University of Colorado, Denver, CO, USA.
Tatiana G KutateladzeDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA. tatiana.kutateladze@cuanschutz.edu.ORCID 0000-0001-7375-6990
University of Colorado Denver · USVan Andel Institute · USUniversity of Colorado Boulder · USUniversity of Leicester · GBUniversity of Colorado Anschutz Medical Campus · US

Funding

Targeting acetylated histone H4 by MLL4R01AG067664 · NIA · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2021 to 2025
$2.1M
Role of GAS41 in Human CancerR01CA204020 · NCI · VAN ANDEL RESEARCH INSTITUTE · PI SHI, XIAOBING · 2016 to 2020
$2.0M
Molecular analysis of ASH1LR01CA252707 · NCI · UNIVERSITY OF COLORADO DENVER · PI TATIANA G KUTATELADZE · 2020 to 2026
$1.9M
The role of JADE in HBO complexesR01HL151334 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2020 to 2023
$1.8M
Epigenetic mechanisms for regulation of p300R01GM135671 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2020 to 2023
$1.4M
Interdomain crosstalk in MORC3R01GM125195 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2017 to 2021
$1.3M
Spatial Organization of Epigenetic Complexes and ChromatinR01GM135286 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI PHIEL, CHRISTOPHER J · 2019 to 2022
$1.3M
p62 in Cancer: Mechanism and RegulationR00CA241301 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI ZHANG, YI · 2021 to 2023
$747k
Q Exactive HF Nanoflow LC Mass Spectrometry SystemS10OD025267 · OD · UNIVERSITY OF COLORADO · PI AHN, NATALIE G. · 2018 to 2018
$600k
Targeting acetylated histone H4 by MLL4R56AG067664 · NIA · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2020 to 2020
$512k
p62 in Cancer: Mechanism and RegulationK99CA241301 · NCI · UNIVERSITY OF COLORADO DENVER · PI ZHANG, YI · 2019 to 2020
$207k
NCI NIH HHS K99 CA241301NCI NIH HHS R00 CA241301NCI NIH HHS R01 CA204020NCI NIH HHS R01 CA252707NHLBI NIH HHS R01 HL151334NIA NIH HHS R01 AG067664NIA NIH HHS R56 AG067664NIGMS NIH HHS R01 GM125195NIGMS NIH HHS R01 GM135286NIGMS NIH HHS R01 GM135671NIH HHS S10 OD025267
6 · The paper itself

Abstract

The transcriptional co-activator and acetyltransferase p300 is required for fundamental cellular processes, including differentiation and growth. Here, we report that p300 forms phase separated condensates in the cell nucleus. The phase separation ability of p300 is regulated by autoacetylation and relies on its catalytic core components, including the histone acetyltransferase (HAT) domain, the autoinhibition loop, and bromodomain. p300 condensates sequester chromatin components, such as histone H3 tail and DNA, and are amplified through binding of p300 to the nucleosome. The catalytic HAT activity of p300 is decreased due to occlusion of the active site in the phase separated droplets, a large portion of which co-localizes with chromatin regions enriched in H3K27me3. Our findings suggest a model in which p300 condensates can act as a storage pool of the protein with reduced HAT activity, allowing p300 to be compartmentalized and concentrated at poised or repressed chromatin regions.

Indexed as

AcetylationCell NucleusCells, CulturedChromatinE1A-Associated p300 ProteinHistone AcetyltransferasesHistonesHumansProtein DomainsTranscription FactorsChromatinE1A-Associated p300 ProteinEP300 protein, humanHistone AcetyltransferasesHistonesTranscription Factors

Identifiers

PMID34326347
PMCPMC8322156
OpenAlexW3185942318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.